Comparative Risk of Major Congenital Malformations With 8 Different Antiepileptic Drugs: A Prospective Cohort Study of the EURAP Registry
Open Access
- 1 March 2019
- journal article
- editorial
- Published by SAGE Publications in Epilepsy Currents
- Vol. 19 (2) , 83-85
Abstract
Teratogenesis of 8 Antiepileptic Drugs in Multinational Experience Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda ...Keywords
This publication has 10 references indexed in Scilit:
- Teratogenicity of antiepileptic dual therapyNeurology, 2018
- Antiepileptic drug combinations not involving valproate and the risk of fetal malformationsEpilepsia, 2016
- Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy RegistersJournal of Neurology, Neurosurgery & Psychiatry, 2014
- Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational studyThe Lancet Neurology, 2013
- Inclusion and exclusion criteria for malformations in newborn infants exposed to potential teratogensBirth Defects Research Part A: Clinical and Molecular Teratology, 2011
- Final results from 18 years of the International Lamotrigine Pregnancy RegistryNeurology, 2011
- Teratogenic Effects of Valproate in the CD-1 Mouse FetusArchives of Neurology, 1985
- The fetal hydantoin syndromeThe Journal of Pediatrics, 1975
- ANTICONVULSANT DRUGS AND CONGENITAL ABNORMALITIESThe Lancet, 1968
- Anticonvulsant Drugs and Congenital Abnormalities1968